Elsevier Webinars

Total Page:16

File Type:pdf, Size:1020Kb

Elsevier Webinars Elsevier Webinars Subscribe to our webinar channel: https://www.brighttalk.com/channel/10439/ Day Time Title Type recorded How to successfully write a research paper? Researcher Academy recorded How to choose the right journal to publish your paper? Researcher Academy recorded SciVal: Data behind SciVal SciVal recorded ScienceDirect Books: High Impact, Relevant Content ScienceDirect, eBooks recorded Mendeley (in Polish ) Mendeley 09.4. 10:00-10:45 SciVal: Visualize research performance Module Overview SciVal Reaxys, Reaxys Medicinal 14.4. 12:00-13:15 Introduction to Reaxys and Reaxys Medicinal Chemistry Chemistry 14.4. 10:00-10:45 SciVal: Benchmark your progress SciVal 15.4. 10:00-10:45 SciVal: Reports - how to use templates SciVal 15.4. 11:00-11:45 Impactful Open Access Journal Publishing Digital Commons 15.4. 12:00-13:45 Scopus: proces oraz kryteria oceny czasopism (in Polish) Scopus SciVal: How to measure your Research Performance in data 15.4. 14:00-14:45 SciVal world? SciVal: Develop collaborative partnerships and analyse 16.4. 10:00-10:45 SciVal research trends Show the world the full spectrum of research produced by 16.4. 11:30-12:30 Digital Commons your university 17.4. 11:00-13:00 Scopus selection criteria and process for journals Scopus 21.4. 10:00-10:45 SciVal: Institutions and Countries SciVal 21.4. 12:00-13:15 Introduction to Embase Embase Best Practices in submitting research for High-Impact Cell Press 21.4. 15:00-16:15 Journals Check your research funding opportunities based on your 22.4. 12:00-12:45 Funding Institutional current output! 23.4. 10:00-10:45 SciVal: Researchers and Publication Sets SciVal 23.4. 11:00-11:45 How can you professionalize your Open Access Journals? Digital Commons 23.4. 12:00-13:00 ScienceDirect: deep dive into the scientific literature ScienceDirect 23.4. 14:00-15:00 Scopus: wealth of world class research Scopus 24.4. 11:30-12:30 How to successfully write a research paper? Researcher Academy 24.4. 14:00-15:00 Scopus: how to choose a good journal wisely Scopus 27.4. 15:00-16:15 Mendeley Mendeley 28.4. 10:00-10:45 SciVal: Topics, Research Areas and Journals SciVal Introduction to ClinicalKey: most current and relevant 28.4. 14:00-15:00 ClinicalKey medical information 04.5. 11:00-12:00 Ethics in publishing Researcher Academy 12.5. 11:00-12:00 How to survive peer review? Researcher Academy 15.5. 11:00-12:00 Working with author profiles in Scopus Scopus .
Recommended publications
  • EMBASE Find Quick, Relevant Answers to Your Biomedical Questions
    EMBASE Find quick, relevant answers to your biomedical questions Piotr Golkiewicz Solution Sales Manager Life Sciences Central and Eastern Europe and Russia Embase® is a registered trademark of Elsevier BV. WHAT IS EMBASE? THE WORLD’S MOST COMPREHENSIVE BIOMEDICAL RESEARCH TOOL Reliable and authoritative content to help the drug and drug-related research community advance new biomedical and pharmaceutical discoveries. Confidence Find all relevant articles that may not otherwise be found by using alternative databases Deep Biomedical Indexing All relevant, up-to-date, biomedical information from the research literature Precise Retrieval Deep and focused research using the most powerful retrieval tools 2 HOW EMBASE DELIVERS VALUE ...by including literature and Conference Scientific In Press We make sure you information resources in a proceedings Journals (unpublished) don’t miss any timely manner biomedical literature ...by reading full-text to The only close identify drugs, diseases, Deep indexing using own taxonomy alternative is adverse affects, clinical (EMTREE) reading trials, drug trade names etc. all the articles ...by enabling advanced search filters to drill down a Very powerful Good precision and comprehensive search to a recall balance relevant and manageable record Search Environment set ...by allowing users to automate Automation and searching and result management documentation E-mail Alerting API Interoperability 3 EMBASE CONTENT 4 EMBASE IS AS COMPREHENSIVE AS POSSIBLE SOURCE TEXT MINING EMBASE SCOPUS Effort / tools required / tools Effort PUBMED GOOGLE 0 % 50 % 100 % Percentage of relevant articles retrieved 5 COMPREHENSIVE CONTENT COVERAGE ON AVERAGE >5000 RECORDS ADDED EACH WORKDAY! Embase: Now covers over 8,400 journals Indexed at Embase (over 5,700 titles) Indexed by MEDLINE (e.g.
    [Show full text]
  • CLINICA CHIMICA ACTA International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine
    CLINICA CHIMICA ACTA International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0009-8981 DESCRIPTION . Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnosticapplication of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
    [Show full text]
  • Searching EMBASE (Elsevier)
    Searching EMBASE (Elsevier) EMBASE description • biomedical and pharmaceutical database • contains all of MEDLINE’s citations and many more unique citations • use when conducting systematic reviews or when searching for information on: food/diet/nutrition, medical devices, or drugs Access EMBASE 1. Go to Ruth Lilly Medical Library Databases. (https://iupui.libguides.com/az.php?s=83627) 2. Scroll down to click on, EMBASE (Elsevier), OR click “E” on the alphabet bar. 3. NOTE: If you are off campus, you will need to enter your university ID and password before you can access this resource. Basic search in EMBASE 1. Identify main concepts. 2. Type terms in the Quick Search Box. 3. Use a single or double quote around a phrase. 4. Use subject headings from EMTREE®. 5. Combine concepts using Boolean operators: AND, OR, NOT Boolean “AND” Boolean “OR” Boolean “NOT” Using AND will retrieve OR will retrieve more NOT will exclude fewer results (ex. heart attacks results (ex. heart attack unwanted terms (ex. AND aspirin) OR myocardial substance abuse NOT infarction) cigarettes). Table 1 Boolean AND, OR, and NOT visualized https://library.mednet.iu.edu/ (317) 274-7182 JCS 5/2020 Results page: Fine-tune your search Filter Results: Beneath the search box: If you click on Quick limits, you will have the options to limit your search to Human subjects and English language. Left-side bar: From most recent search, click each filter to see how many articles are in that subset: e.g. age, gender, drugs used, and other diseases. Work with Search History: • Combine searches using AND; OR • Select any search in History to recall the results.
    [Show full text]
  • Journals 2016 Catalog Directors’ Letter
    MIT Press Journals 2016 catalog Directors’ Letter Dear Friends, The MIT Press celebrated its 50th anniversary in 2012, and the inclination to ponder our distinguished history remains strong, perhaps even more so this year with the change in Press leadership—Amy Brand was named Director of the MIT Press in July of 2015. The Press’s journals division, which was founded in 1972, ten years after the books division, also has a significant publishing legacy to consider, with over 80 journals published since the division’s inception. Some, such as Linguistic Inquiry and The Journal of Interdisciplinary History, have grown with us from the very beginning. Other core titles like International Security, October, The Review of Economics and Statistics and Journal of Cognitive Neuroscience joined the Press over the following decades, providing a solid base for the high-quality and innovative scholarship that our journals division is well known for. Today, we continue to push the boundaries of scholarly publishing and communication. We relish discovering new fields to publish in, and working with scholars who are establishing new domains of research and inquiry. In keeping with that spirit, the Press is proud to launch a new open access journal in 2016, Computational Psychiatry, to serve a burgeoning field that brings together experts in neuroscience, decision sciences, psychiatry, and computation modeling to apply new quantitative techniques to our understanding of psychiatric disorders. Developing new ways of delivering journal articles and providing a richer range of metrics around their usage and impact is another current effort. On our mitpressjournals.org site, the Press is providing Altmetric badges for select titles to give an improved sense of the breadth of a journal article’s reach.
    [Show full text]
  • Enriching Chemistry Database Content with Human-Like Indexing of Documents
    WHITE PAPER Enriching Chemistry Database Content with Human-Like Indexing Of Documents APPLYING THE POWER OF A TAXONOMY WITH 450 MILLION TERMS Taxonomies are used to index content in databases, making facts and literature discoverable. The size of some taxonomies can make this task daunting. A comprehensive taxonomy to describe chemistry uses roughly 450 million terms, making it ~450 times the size of the English language and ~150 times the size of the next nearest discipline-specific taxonomy. To ensure that Reaxys® fully facilitates discoverability in the far-reaching and complex discipline of chemistry, two processes occur alongside each other: the familiar manual indexing and excerption method; and a novel automatic but human-like indexing process. How can the content in a large and diverse database be made highly discoverable? The English language has over 1 million words. How many do you think the average person can recognize? The online survey TestYourVocab.com enables visitors to test the size of their English vocabulary. The results reveal interesting trends. Data on roughly 450,000 native English speakers shows that most adult survey participants have a vocabulary size of 20,000 to 35,000 words. These are words that they can recognize and define. Topping the charts were individuals who came near 40,000 words. While these figures do not represent the average English-speaking population—it takes a certain type of person to respond to such surveys—and may be biased by the data collection methodology, the survey results hint at an upper limit to the word and concept retention capacity of the human brain.
    [Show full text]
  • Botanica Marina 2017 · FEBRUARY · Volume 60 · Number 1 · PAGES 1–84
    Botanica MARINA 2017 · FEBRUARY · VOLUME 60 · NUMBER 1 · PAGES 1–84 EDITOR-IN-CHIEF Matthew J. Dring, Belfast/Portaferry, Northern Ireland (–2020) ASSOCIATE EDITORS Kirsten Heimann, Townsville, Australia (–2020) Ka-Lai Pang, Keelung, Taiwan (–2020) Georg Pohnert, Jena, Germany (–2017) Michel Poulin, Ottawa, Canada (–2020) EDITORIAL BOARD Charles D. Amsler, Birmingham, USA (–2020) Inka Bartsch, Bremerhaven, Germany (−2018) John Beardall, Clayton, Australia (–2017) John A. Berges, Milwaukee, USA (–2020) Sung Min Boo, Daejeon, Korea (–2018) Olivier De Clerck, Ghent, Belgium (–2018) Jeffrey L. Gaeckle, Olympia, USA (−2018) Mona Hoppenrath, Wilhelmshaven, Germany (–2018) Catriona Hurd, Hobart, Australia (−2018) Gavin W. Maneveldt, Bellville, South Africa (–2018) Michael J. Wynne, Ann Arbor, USA (–2020) Abstracted/INDEXED IN AGRICOLA (National Agricultural Library); Baidu Scholar; Cabell’s Directory; CABI (over 50 subsections); Celdes; Chemical Abstracts Service (CAS) - CAplus; Chemical Abstracts Service (CAS) - SciFinder; CNKI Scholar (China National Knowledge Infrastructure); CNPIEC; EBSCO (relevant databases); EBSCO Discovery Service; Elsevier - BIOBASE/CABS (Current Awareness in Biological Sciences); Elsevier - Fluidex; Elsevier - Geobase; Elsevier - Reaxys; Elsevier - SCOPUS; Gale/Cengage; Genamics JournalSeek; Google Scholar; J-Gate; JournalTOCs; KESLI-NDSL (Korean National Discovery for Science Leaders); Naviga (Softweco); NISC SA: Fish and Fisheries Worldwide; NISC SA: Water Resources Worldwide; Primo Central (ExLibris); ProQuest (relevant
    [Show full text]
  • View Document
    11/07/2017 Embase Select Language ▼ Logout Session Results / Record 4 of 173 Full record Record 4 Similar records | Add to Clipboard | Email Record The utilisation of modern transport and telecommunications platforms to assist in the remote provision of paediatric cancer diagnostics in Tanzania Mcdermott M., O'Hare K., Scanlon P., Grehan D., Rooney S., Laiti R., Kaijage J., Jumanne S., O'Sullivan M. Pediatric Blood and Cancer 2016 63 Supplement 3 (S71) Go to publisher for the full text Abstract Background/Objectives: The acquisition of a pathologic diagnosis represents a critical point in the management of children with malignant disease, allowing staff to plan a therapeutic pathway. In resource poor settings, diagnoses help to identify children who will benefit from the limited interventions available and those who will not. Access to timely diagnoses can be a challenge in low and middle income countries. While enhanced local laboratory capacity is the ultimate answer, interim solutions are needed to assist programs with existing deficits. Modern transport and telecommunications technology can facilitate this process. Design/Methods: Muhimbili University, Dar es Salaam, provides a paediatric cancer program for Tanzania. As part of a formal twinning arrangement, laboratory staff in Dublin have provided interim diagnostic services while helping to develop local paediatric cancer diagnostic capacity in Tanzania. Samples are transported free via DHL® couriers. Preliminary reports are communicated to local clinical staff via WhatsApp with final reports scanned and e-mailed. Results: Since 2008, almost 1000 cancer samples have been transported from Dar to Dublin. Transport time is two working days. In 92% of cases, a preliminary communication regarding specimen adequacy and provisional diagnosis was communicated via WhatsApp the day after receipt.
    [Show full text]
  • Empowering Knowledge™
    Elsevier at a Glance Empowering Knowledge™ Empowering Knowledge™ Technological advancement and the data revolution have pushed the boundaries of science and medicine. Discoveries unimaginable a generation ago are uncovered every day. At Elsevier, we recognize the potential for scientists and clinicians to find new answers, reshape human knowledge and tackle the most urgent global crises. We want to make analysis easier for everyone working in science and medicine, enabling them to manage their work more efficiently and spend more time making breakthroughs. That’s why Elsevier is evolving. Growing from our roots in publishing, we’re creating analytical solutions to serve the needs of science and health. 3 Opportunities Abound Elsevier employs over 1,000 technologists. We work with cutting-edge technologies to 81% create analytics solutions that help advance science, technology and healthcare. of our revenue comes from digital products. 530+ m 475 m 4 TB standardized assessment items scientific facts extracted from data of about 9,000 institutions administered by HESI to students in ScienceDirect in over 180 countries, turned into North America in the past 12 years. using machine reading. 171 trillion metrics per week using big data analytics since 1996. 4 Craig C. Mello medicine, 2006 Françoise Barré-Sinoussi medicine, 2008 Sir Martin J. Evans medicine, 2007 Masatoshi Koshiba physics, 2002 Finn E. Kydland economics, 2004 Leonid Hurwicz economics, 2007 Since the year 2000, more than 99% of the Nobel laureates in science and economics have published in Elsevier journals. Trusted Information Every tool we develop is built on trusted At Elsevier, we have partnered with the information – because from the library to the lab, scholarly community for 140 years to curate and verify knowledge.
    [Show full text]
  • Vol 42 Iss S1 April 2021 Vol 42 | Iss S1 | April 2021 Abstracts
    Vol 42 Iss S1 April 2021 Vol Vol 42 | Iss S1 | April | 2021 Abstracts Top Six Abstracts T2 One Year Follow up Results of the DETECT Enzymatic Debridement Multicenter RCT T1 Initial Results of the American Burn Association (ABA) Multi-Center Evaluation William L. Hickerson, MD, Jeremy Goverman, MD, on the Effectiveness of the Burn Navigator Sigrid A. Blome-Eberwein, MD, Adam Singer, MD, Lucy Wibbenmeyer, MD, Nicholas Meyer, MD, Julie A. Rizzo, MD FACS, Maria L. Serio-Melvin, Joshua S. Carson, MD, FACS, James Gallagher, MD, MSN RN, Elsa Coates, MS, RN, CCRN, FACS, Steven Kahn, MD, Dhaval Bhavsar, MBBS, Nehemiah T. Liu, MS, Jose Salinas, PhD David Mozingo, MD, Tam N. Pham, MD, FACS, United States Army Institute of Surgical Research, Nicole S. Gibran, MD, FACS, Jeffrey W. Shupp, Fort Sam Houston, Texas MD, FACS, Kevin N. Foster, MD, MBA, FACS, Giavonni M. Lewis, MD, FACS, Julie Caffrey, DO, Introduction: The Burn Navigator (BN) is an FDA-cleared MS, FACOS, Yaron Shoham, MD clinical decision support tool used to aid fluid resuscitation Firefighters’ Regional Burn Center, Memphis, Tennes- after major burn injury. The BN provides users with hourly see; Massachusetts General Hospital, Boston, Massa- recommendations for fluid titration during the initial resus- chusetts; LVHN, Allentown, Pennsylvania; Renais- citation based on various factors. The objective of this multi- sance School of Medicine at Stony Brook University, center observational study was to evaluate the resuscitation Stony Brook, New York; University of Iowa Hospitals volumes and related outcomes of patients admitted to five & Clinics, Iowa City, Iowa; Columbia-St. Mary’s ABA verified burn centers who underwent intravenous fluid Milwaukee Campus, Milwaukee, Wisconsin; UF resuscitation utilizing the BN.
    [Show full text]
  • Reaxys® Fact Sheet
    R&D SOLUTIONS Reaxys® Fact Sheet The shortest path to chemistry data and literature Designed to support the full range of chemistry research, including pharmaceutical development, environmental health & safety work and material science, Reaxys puts every scientist, from beginner to expert, on the shortest path to answers. Chemistry queries are launched from the highly intuitive search interface to quickly retrieve relevant literature, patent information, valid compound properties and experimental procedures. Finding answers has never been easier. Introduction Reaxys provides rapid and easy access to experimental facts to empower chemistry research, chemical discovery and scientific education. Finding relevant literature, retrieving precise compound properties and reaction data, and incorporating that information into research workflows has never been easier. Reaxys improves R&D productivity by putting scientists on the shortest path to relevant chemistry answers. Question Answered with • Does this compound exist? • The latest chemistry literature and patents • What do we know about it? • Excerpted data on properties, reactions & more • How can I obtain it? • Interactive synthesis plans & sourcing info • Is it involved in novel research? • Patent data from every relevant patent office • Who else is working on it? • Direct links to Scopus for detailed information >119M >46M >500M organic, inorganic chemical reactions published and organometallic experimental facts compounds >16,000 >240 6 chemistry-related years of chemistry indexing sources for a periodicals knowledge cross-disciplinary view of chemistry FEATURES Find chemistry where it is used: in engineering, geology, medicine and more To ensure that Reaxys fully facilitates discoverability in the far-reaching and complex discipline of chemistry, two indexing processes occur alongside each other.
    [Show full text]
  • Search Worksheet
    Search Worksheet Search Steps 1. State the research topic/clinical question as an answerable question – use a consistent method to frame the question, such as PICO(M) or its variants. Refer to Tables 2 and 3 on the back side. 2. Identify appropriate databases – refer to Table 4 on the back side. Do not rely on a single database. 3. Identify possible search terms, keywords, and synonyms based on concepts identified in step 1. 4. Conduct the search in the selected databases – search each concept separately. Use: OR – Combines synonyms, related terms, or spelling variations for each concept. (OR means more.) AND – Combine concepts to find citations which are “about” all of the concepts. (AND means less.) 5. Apply limits to narrow search results to relevant citations 6. Refine and save search Table 1 – Organize your search plan. State the research topic/clinical question as an answerable question. Concepts Concept 1 Concept 2 Concept 3 Concept 4 Identify key concepts Identify subject headings for each key concept Identify keywords for each key concept Apply limits, i.e., Publication Types, Age Groups, Years, Language, etc. 213 - Dec-20 Table 2 – PICO(M) Components P Patient or Problem What is the important patient problem or condition? How would you describe the important characteristics of the patient? Intervention, Indicator, What do you want to do to help the patient? Do you want to consider a specific treatment, diagnostic test, exposure or risk I Exposure, Prognostic Factor factor? Is there a prognostic factor that might affect the
    [Show full text]
  • Annual Reports and Financial Statements 2014 Statements Financial and Reports Annual
    Annual Reports and Financial Statements 2014 Annual Reports and Financial Statements www.relxgroup.com 2014 21654 Reed AR 2014 Cover Outer and Inner.indd 1-3 05/03/2015 18:52 RELX Group is a world-leading provider of information solutions for professional customers Credits across industries. Designed and produced by We help scientists make new discoveries, lawyers mslgroup.com Board photography by win cases, doctors save lives, and executives forge Douglas Fry, Piranha Photography Printed by commercial relationships with their clients. We help Pureprint Group, ISO14001, FSC® certified and CarbonNeutral® The 2014 Annual Reports and Financial Statements is printed insurance groups offer customers lower prices using paper containing a minimum of 75% recycled content, of which 100% is de-inked post-consumer waste. All of the pulp by assessing risk better, and save taxpayers and is bleached using an elemental chlorine free process (ECF). Printed in the UK by Pureprint using their environmental printing technology; vegetable inks were used throughout. Pureprint is a consumers money by enabling governments and CarbonNeutral® company. Both manufacturing mill and printer are ISO14001 registered and are Forest Stewardship Council® financial groups to detect fraud. (FSC) chain-of-custody certified. RELX Group is owned by two parent companies: Reed Elsevier PLC is the London Stock Exchange listed vehicle for holding shares in RELX Group. Shareholders in Reed Elsevier PLC own a 52.9% economic interest in the Group. Reed Elsevier NV is the Amsterdam Stock Exchange listed vehicle for holding shares in RELX Group. External shareholders in Reed Elsevier NV own a 47.1% economic interest in the Group.
    [Show full text]